Evidence map›Paper›PMID 39305363›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

Treatment outcomes and their predictors in children hospitalized with varicella complicated by bacterial superinfections after pandemic of COVID-19 - a retrospective multicenter analysis of real-life data in Poland.

Maria Pokorska-Śpiewak, Leszek Szenborn, Maja Pietrzak, Magdalena Marczyńska, Anna Mania, Lidia Stopyra, Justyna Moppert, Kacper Toczyłowski, Artur Sulik, Filip Szenborn and 9 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maria Pokorska-ŚpiewakDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. maria.pokorska-spiewak@wum.edu.pl.
Leszek SzenbornDepartment of Pediatrics and Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland.
Maja PietrzakDepartment of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases, Warsaw, Poland.
Magdalena MarczyńskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Anna ManiaDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Lidia StopyraDepartment of Infectious Diseases and Pediatrics, Department of Pediatrics, Żeromski Specialist Hospital in Krakow, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
Justyna MoppertDepartment of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
Kacper ToczyłowskiDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland.
Artur SulikDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland.
Filip SzenbornFaculty of Information and Communication Technology, Wroclaw University of Science and Technology, Wroclaw, Poland.
Jolanta JasonekDepartment of Pediatrics and Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland.
Inga Barańska-NowickaDepartment of Pediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland.
Adrianna BuciakDepartment of Pediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland.
Ewa Majda-StanisławskaDepartment of Pediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland.
Przemysław CiechanowskiDepartment of Pediatrics and Infectious Diseases, Regional Hospital in Szczecin, Szczecin, Poland.
Katarzyna KarnyDepartment of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.
Ernest KucharDepartment of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.
Magdalena FiglerowiczDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Małgorzata PawłowskaDepartment of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to analyze treatment outcomes and their predictors in children hospitalized due to varicella complicated by bacterial superinfections after pandemic of COVID-19.

methodsThis retrospective study analyzed data collected in a multicenter, nationwide, observational database dedicated for children aged 0-17 years hospitalized due to bacterial complications of varicella in 9 Polish tertiary healthcare inpatient centers. The primary endpoint of this study was the treatment outcome established after the end of hospital management assessed at a 4-point scale. The secondary endpoint was defined as the necessity of surgical intervention.

resultsThere were 458 patients with a median age of 4 (IQR 2-6) years. After the completed treatment, 319 (69%) participants were found fully recovered; 132 (29%) had transient complications; 2 (0.5%) had persistent complications; and 1 child (0.5%) died. Multivariate analysis revealed that implementation of ibuprofen in pre-treatment management of a child with varicella was associated with a 4.07-fold (2.50-6.60) increase in risk of complications after the treatment and it was associated with 2.87 times (1.39-5.89) higher risk of surgical intervention necessity. For other pre-hospital interventions (implementation of acyclovir, antibiotics or antihistaminics) no significant impact was observed. GAS infection increased the necessity of surgical intervention by 7.51 (3.64-15.49) times.

conclusionsOne-third of patients treated for bacterial complications of varicella have post-treatment complications, most of them transient. GAS infection increases the need for surgical intervention. The use of ibuprofen in the treatment of varicella significantly increases the risk of complications and the need for surgical intervention.

Indexed as

ChickenpoxCOVID-19HospitalizationAdolescentAnti-Bacterial AgentsBacterial InfectionsChildChild, PreschoolFemaleHumansIbuprofenInfantInfant, NewbornMalePolandRetrospective StudiesAnti-Bacterial AgentsIbuprofenAntipyreticsGroup a streptococcus (streptococcus pyogenes)IbuprofenVaricella

Identifiers

PMID39305363
PMCPMC11608362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.